List of Roche's Acquisitions
Here's the year on year acquisition history of Roche:
Year | # Acquisitions |
|---|---|
2025 | 1 |
2024 | 3 |
2023 | 2 |
2022 | 1 |
2021 | 2 |
2020 | 3 |
2019 | 2 |
2018 | 2 |
2017 | 3 |
2016 | 1 |
2015 | 8 |
2014 | 7 |
2011 | 2 |
2010 | 2 |
2009 | 1 |
2008 | 4 |
2007 | 4 |
2005 | 1 |
2003 | 1 |
2001 | 1 |
Recent acquisitions by Roche
Roche's most recent acquisition - 89bio is a Developer of therapies for treating nonalcoholic steatohepatitis and other liver and metabolic disorders, founded in 2018 and located in San Francisco. Roche acquired it in September 2025 for a price of $*****.
Here is the list of all acquisitions by Roche sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Sep 17, 2025 | bfve | glnr | 58 | 927 | |
Nov 26, 2024 | gs{l | emjr | 89 | 113 | |
Sep 30, 2024 | wqln | hbsn | 65 | 252 | |
Jan 02, 2024 | {epo | fqwo | 83 | 381 | |
Dec 04, 2023 | nbwf | vzjm | 71 | 578 |
View the full list of acquisitions
Sign Up for FreeNews related to Roche's acquisitions
Media has covered Roche for a total of 186 events in the last 1 year, 41 of them have been about acquisition activity.
•
•
•
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier assetBioSpace•Oct 05, 2026•Alector, Genentech, NeOnc Technologies Holdings, Roche and 2 others
•
•
Roche bets up to $1B to advance next-gen bispecifics with DualitasBioSpace•Sep 17, 2026•Roche, Dualitas Therapeutics, Atavistik
•
Treeline Biosciences and Roche Partner for Phase I BCL Lymphoma Trialhttps://www.clinicaltrialsarena.com/•Sep 03, 2026•Roche
•
Hanmi Pharm inks $2.3B licensing deal with Genentech for obesity drug candidateThe Korea Times•Aug 24, 2026•Hanmi, Genentech, Roche, co.kr and 1 other
•
Roche inks $2.4B deal to buy out Foundation Medicine - SwitzerlandEUROPE SAYS•Aug 23, 2026•Roche and Foundation Medicine, Roche
•
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation StudiesPR Newswire•Aug 03, 2026•Roche, Genprex, Evexta Bio
•
Nurix Therapeutics GAAP EPS of -$0.81 misses by $0.08, revenue of $9.04M misses by $6.25MSeeking Alpha•Jul 09, 2026•Nurix Therapeutics, Roche
